This inventor holds 1 USPTO granted patent. Top assignee: Sygnis Bioscience Gmbh & Co Kg. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Annette Trutzel: Innovator in Neuronal Protein Kinase Research
Introduction
Annette Trutzel is a prominent inventor based in Frankenthal, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic approaches for neurological conditions. Her work focuses on the molecular mechanisms underlying neuronal health and disease.
Latest Patents
Annette Trutzel holds a patent for a nucleic acid molecule encoding a neuronal serine-threonine protein kinase. This invention relates to a gene and the coded protein involved in the development of sequelae of local ischaemia. The new protein is a serine-threonine protein kinase, which provides a novel therapeutic approach to the prophylaxis and therapy of apoplexy. This patent highlights her innovative contributions to medical science.
Career Highlights
Trutzel is associated with Sygnis Bioscience GmbH & Co. KG, where she continues to advance her research in biotechnology. Her work has garnered attention for its potential impact on treating neurological disorders. With a focus on the intersection of genetics and therapeutic development, she is paving the way for new medical solutions.
Collaborations
Throughout her career, Annette has collaborated with notable colleagues, including Gisela Eisenhardt and Rohini Kuner. These partnerships have enriched her research and expanded the scope of her innovations.
Conclusion
Annette Trutzel's work exemplifies the vital role of inventors in advancing medical science. Her contributions to the understanding of neuronal protein kinases are paving the way for new therapeutic strategies.